Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCCR
Schwab Core Bond ETF
SCCR
|
+$623M |
| 2 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$608M |
| 3 |
Applovin
APP
|
+$402M |
| 4 |
Amazon
AMZN
|
+$340M |
| 5 |
Lockheed Martin
LMT
|
+$307M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$542M |
| 2 |
JPMorgan Chase
JPM
|
+$289M |
| 3 |
HES
Hess
HES
|
+$275M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$266M |
| 5 |
ANSS
Ansys
ANSS
|
+$210M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.34% |
| 2 | Financials | 11.49% |
| 3 | Consumer Discretionary | 9.42% |
| 4 | Healthcare | 9.25% |
| 5 | Industrials | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3401
VistaGen Therapeutics
VTGN
$11.9M
| $82.7K | ﹤0.01% |
23,302
| – | – |
|
|
CIRC
3402
Circle8 Group
CIRC
$66.6M
| $81.5K | ﹤0.01% |
26,705
| – | – |
|
3403
Tenaya Therapeutics
TNYA
$168M
| $81K | ﹤0.01% |
+50,000
| New | +$50.4K |
|
|
NXXT
3404
NextNRG Inc
NXXT
$47M
| $80.2K | ﹤0.01% |
43,807
+32
| +0.1% | +$56 |
|
|
FLNA
3405
Filana Therapeutics
FLNA
$46.9M
| $75.8K | ﹤0.01% |
26,049
-239,241
| -90% | -$550K |
|
3406
Myomo
MYO
$59.8M
| $72.8K | ﹤0.01% |
81,566
-21,495
| -21% | -$31.3K |
|
3407
Atossa Therapeutics
ATOS
$23.6M
| $69.4K | ﹤0.01% |
5,333
| – | – |
|
3408
One Stop Systems
OSS
$317M
| $69.2K | ﹤0.01% |
12,911
| – | – |
|
|
CV
3409
CapsoVision Inc
CV
$330M
| $68.2K | ﹤0.01% |
+14,091
| New | +$59.1K |
|
3410
Intellicheck
IDN
$76.3M
| $67.4K | ﹤0.01% |
12,962
| – | – |
|
3411
Research Solutions
RSSS
$70.9M
| $67.4K | ﹤0.01% |
18,069
| – | – |
|
3412
Fossil Group
FOSL
$310M
| $64.3K | ﹤0.01% |
+25,000
| New | +$59K |
|
3413
Zentalis Pharmaceuticals
ZNTL
$295M
| $63.4K | ﹤0.01% |
41,981
-257,116
| -86% | -$385K |
|
3414
flyExclusive
FLYX
$68.4M
| $63.2K | ﹤0.01% |
+12,799
| New | +$43.8K |
|
3415
RenovoRx
RNXT
$51.9M
| $62.5K | ﹤0.01% |
49,232
| – | – |
|
|
SBC
3416
SBC Medical Group
SBC
$328M
| $61.9K | ﹤0.01% |
14,267
| – | – |
|
|
MRDN
3417
Meridian Holdings Inc
MRDN
$177M
| $61.1K | ﹤0.01% |
4,504
-691
| -13% | -$11.3K |
|
3418
Tevogen Inc. Common Stock
TVGN
$28.1M
| $60.1K | ﹤0.01% |
1,530
| – | – |
|
3419
Aemetis
AMTX
$123M
| $58.6K | ﹤0.01% |
+26,060
| New | +$69.2K |
|
3420
NN Inc
NNBR
$301M
| $58.5K | ﹤0.01% |
28,401
| – | – |
|
|
GOCO
3421
DELISTED
GoHealth
GOCO
| $58.1K | ﹤0.01% |
12,060
| – | – |
|
|
AGEN
3422
Agenus
AGEN
$307M
| $58K | ﹤0.01% |
15,066
+5
| +0% | +$25 |
|
3423
NeoVolta
NEOV
$178M
| $57.8K | ﹤0.01% |
12,964
| – | – |
|
3424
Coya Therapeutics
COYA
$113M
| $57K | ﹤0.01% |
10,000
| – | – |
|
3425
Black Diamond Therapeutics
BDTX
$120M
| $54.9K | ﹤0.01% |
14,484
| – | – |
|
Similar funds
Charles Schwab's Q3 2025 Portfolio in Review
As of Q3 2025, Charles Schwab held 3,560 positions worth $626B, up 8.3% from $578B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q3 2025: portfolio turnover was 4.8%. Charles Schwab opened 66 new positions and exited 105, leaving the 3,560-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Financials and Consumer Discretionary.
- Charles Schwab's largest Q3 2025 buy was BitMine Immersion Technologies: 1,712,780 shares worth $88.9M.
- Charles Schwab added most to Schwab Core Bond ETF in Q3 2025, an estimated $623M increase.
- Charles Schwab's biggest Q3 2025 reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, cutting an estimated $542M.
- Charles Schwab fully exited Hess in Q3 2025, selling an estimated $275M.
- Charles Schwab's ten largest holdings make up 25% of its $626B portfolio in Q3 2025.
- Charles Schwab opened 66 new positions and closed 105 in Q3 2025.
- Charles Schwab's portfolio value rose 8.3% quarter-over-quarter to $626B.
Based on Charles Schwab's 13F filing for Q3 2025, filed 10 Nov 2025.